PL1522312T3 - Biologicznie stabilna ciekła kompozycja FVIII lub vWF, lub kompleksu FVIII/vWF pochodzenia ludzkiego - Google Patents

Biologicznie stabilna ciekła kompozycja FVIII lub vWF, lub kompleksu FVIII/vWF pochodzenia ludzkiego

Info

Publication number: PL1522312T3
Authority: PL; Poland
Prior art keywords: fviii; vwf; liquid composition; human origin; stable liquid
Prior art date: 2003-10-03

Application number

PL04380188T

Other languages

English (en)

Inventor

Gamon Salvador Grancha

Nieto Juan Ignacio Jorquera

Debart Pere Ristol

Riera Marta Massot

Original Assignee

Grifols Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-03

Filing date

2004-09-24

Publication date

2007-08-31

2004-09-24 Application filed by Grifols Sa filed Critical Grifols Sa

2007-08-31 Publication of PL1522312T3 publication Critical patent/PL1522312T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

PL04380188T 2003-10-03 2004-09-24 Biologicznie stabilna ciekła kompozycja FVIII lub vWF, lub kompleksu FVIII/vWF pochodzenia ludzkiego PL1522312T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200302298A ES2229931B1 (es)	2003-10-03	2003-10-03	Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.
EP04380188A EP1522312B1 (en)	2003-10-03	2004-09-24	Biologically stable liquid composition of FVIII, of vWF or of FVIII/vWF complex of human origin.

Publications (1)

Publication Number	Publication Date
PL1522312T3 true PL1522312T3 (pl)	2007-08-31

Family

ID=34307115

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04380188T PL1522312T3 (pl)	2003-10-03	2004-09-24	Biologicznie stabilna ciekła kompozycja FVIII lub vWF, lub kompleksu FVIII/vWF pochodzenia ludzkiego

Country Status (13)

Country	Link
US (1)	US20050074866A1 (pl)
EP (1)	EP1522312B1 (pl)
JP (1)	JP4388875B2 (pl)
AR (1)	AR047756A1 (pl)
AT (1)	ATE357245T1 (pl)
CA (1)	CA2481593C (pl)
DE (1)	DE602004005392T2 (pl)
ES (2)	ES2229931B1 (pl)
HK (1)	HK1075406A1 (pl)
MX (1)	MXPA04009246A (pl)
PL (1)	PL1522312T3 (pl)
PT (1)	PT1522312E (pl)
UY (1)	UY28531A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0413276B8 (pt) *	2003-08-05	2021-05-25	Novo Nordisk As	derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica
CN101389650B (zh)	2005-12-28	2012-10-10	诺沃-诺迪斯克有限公司	包含酰化胰岛素和锌的组合物以及制备所述组合物的方法
CN101677947B (zh) *	2007-06-13	2013-07-17	诺沃-诺迪斯克有限公司	包含胰岛素衍生物的药物制剂
ES2887187T3 (es) *	2007-12-28	2021-12-22	Takeda Pharmaceuticals Co	Formulaciones de VWF recombinante
US20100099603A1 (en) *	2008-10-21	2010-04-22	Baxter International Inc.	Lyophilized recombinant vwf formulations
US11197916B2 (en)	2007-12-28	2021-12-14	Takeda Pharmaceutical Company Limited	Lyophilized recombinant VWF formulations
KR20110085985A (ko) *	2008-10-30	2011-07-27	노보 노르디스크 에이/에스	하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료
RU2013123515A (ru)	2010-10-27	2014-12-10	Ново Нордиск А/С	Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
KR20140083035A (ko)	2011-10-18	2014-07-03	체에스엘 베링 게엠베하	인자 ｖｉｉｉ의 생체이용률을 증가시키기 위한 황산화 글리코사미노글리칸과 하이알루로니다제의 병용 사용
JP2015515482A (ja)	2012-04-24	2015-05-28	ノヴォノルディスクアー／エス	血友病の治療に適する化合物
EP2991672A1 (en)	2013-04-30	2016-03-09	Novo Nordisk A/S	Novel administration regime
WO2015066769A1 (en)	2013-11-08	2015-05-14	Csl Ltd.	New method to concentrate von willebrand factor or complexes thereof
US10335464B1 (en)	2018-06-26	2019-07-02	Novo Nordisk A/S	Device for titrating basal insulin
AU2022258553A1 (en)	2021-04-13	2023-11-02	Grifols Worldwide Operations Limited	Liquid composition comprising factor viii or factor viii/von willebrand factor complex
AU2022326188A1 (en) *	2021-08-11	2024-02-22	Grifols Worldwide Operations Limited	Method for producing human plasma-derived factor viii / von willebrand factor and composition obtained

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4359463A (en) *	1980-11-26	1982-11-16	Rock Gail A	Stabilization of Factor VIII activity in whole blood or blood plasma
JPS59116228A (ja) *	1982-12-24	1984-07-05	Green Cross Corp:The	血液凝固第８因子脂肪小体製剤の製法
AT379510B (de) *	1983-05-20	1986-01-27	Immuno Ag	Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
FR2651437A1 (fr) *	1989-09-05	1991-03-08	Lille Transfusion Sanguine	Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
DE4111393A1 (de) *	1991-04-09	1992-10-15	Behringwerke Ag	Stabilisierte faktor viii-praeparationen
WO1993022336A1 (en) *	1992-04-30	1993-11-11	Alpha Therapeutic Corporation	Improved solubilization and stabilization of factor viii complex
SE504074C2 (sv) *	1993-07-05	1996-11-04	Pharmacia Ab	Proteinberedning för subkutan, intramuskulär eller intradermal administrering
IL113010A0 (en) *	1994-03-31	1995-10-31	Pharmacia Ab	Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
SE9403915D0 (sv) *	1994-11-14	1994-11-14	Annelie Almstedt	Process A
SE9501189D0 (sv) *	1995-03-31	1995-03-31	Pharmacia Ab	Protein formulation
US5925738A (en) *	1995-12-01	1999-07-20	The American National Red Cross	Methods of production and use of liquid formulations of plasma proteins
US6320029B1 (en) *	1996-11-29	2001-11-20	The American National Red Cross	Methods of production and use of liquid formulations of plasma proteins
DK1194161T3 (da) *	1999-07-13	2006-02-13	Biovitrum Ab	Stabile faktor VIII-sammensatninger

2003
- 2003-10-03 ES ES200302298A patent/ES2229931B1/es not_active Expired - Fee Related
2004
- 2004-07-20 AR ARP040102555A patent/AR047756A1/es not_active Application Discontinuation
- 2004-09-14 CA CA002481593A patent/CA2481593C/en not_active Expired - Lifetime
- 2004-09-21 US US10/946,378 patent/US20050074866A1/en not_active Abandoned
- 2004-09-22 UY UY28531A patent/UY28531A1/es not_active Application Discontinuation
- 2004-09-23 MX MXPA04009246A patent/MXPA04009246A/es active IP Right Grant
- 2004-09-24 PT PT04380188T patent/PT1522312E/pt unknown
- 2004-09-24 DE DE602004005392T patent/DE602004005392T2/de not_active Expired - Lifetime
- 2004-09-24 AT AT04380188T patent/ATE357245T1/de active
- 2004-09-24 EP EP04380188A patent/EP1522312B1/en not_active Expired - Lifetime
- 2004-09-24 ES ES04380188T patent/ES2280924T3/es not_active Expired - Lifetime
- 2004-09-24 PL PL04380188T patent/PL1522312T3/pl unknown
- 2004-10-01 JP JP2004289910A patent/JP4388875B2/ja not_active Expired - Fee Related
2005
- 2005-10-13 HK HK05109078A patent/HK1075406A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
UY28531A1 (es)	2005-03-31
PT1522312E (pt)	2007-06-19
ES2229931B1 (es)	2006-01-16
DE602004005392T2 (de)	2007-12-06
HK1075406A1 (en)	2005-12-16
DE602004005392D1 (de)	2007-05-03
CA2481593C (en)	2009-10-20
MXPA04009246A (es)	2005-04-06
JP2005112855A (ja)	2005-04-28
EP1522312A1 (en)	2005-04-13
ATE357245T1 (de)	2007-04-15
US20050074866A1 (en)	2005-04-07
EP1522312B1 (en)	2007-03-21
AR047756A1 (es)	2006-02-22
JP4388875B2 (ja)	2009-12-24
ES2229931A1 (es)	2005-04-16
CA2481593A1 (en)	2005-04-03
ES2280924T3 (es)	2007-09-16

Publication	Publication Date	Title
GB2414990B (en)	2007-05-23	Biologically active native biomatrix composition
IL174637A0 (en)	2006-08-20	Fibrosis-inducing agents, compositions containing the same and medical implants containing the same
IL163552A (en)	2010-11-30	Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
IL173299A (en)	2015-05-31	2,4-Pyrimidindiamine derivatives, preparations containing them and their use
PL381247A1 (pl)	2007-05-14	Skondensowana pochodna heterocykliczna, zawierająca ją kompozycja lecznicza, oraz jej zastosowanie lecznicze
PL1522312T3 (pl)	2007-08-31	Biologicznie stabilna ciekła kompozycja FVIII lub vWF, lub kompleksu FVIII/vWF pochodzenia ludzkiego
EP1552814A4 (en)	2006-03-01	FRAGRANCE COMPOSITION
AP2003002907A0 (en)	2003-12-31	Liquid pharmaceutical composition.
HUP0301654A3 (en)	2007-08-28	Novel n-pyrimidinyl-sulfamides, their use as endothelin receptor antagonists and pharmaceutical compositions containing them
HUP0303825A3 (en)	2005-06-28	1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them
EP2415760A3 (en)	2012-02-22	CCR-9 antagonists
AU2003249812A8 (en)	2004-02-09	Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents
GB0208696D0 (en)	2002-05-29	Fabric treatment composition
HUP0401638A3 (en)	2012-09-28	Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
IL173929A0 (en)	2006-07-05	Analogues of kahalalide f and pharmaceutical compositions containing the same
MXPA03006629A (es)	2003-10-15	Composicion para el cuidado de la piel.
IL175369A0 (en)	2008-04-13	Novel compound, corresponding compositions, preparation and/or treatment methods
MXPA03007314A (es)	2003-12-04	Composicion para la piel para reducir aceites y grasa de la piel.
ZA200210316B (en)	2003-07-04	Composition and its therapeutic use.
HUP0303469A3 (en)	2004-04-28	Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
BRPI0313645A2 (pt)	2017-12-12	composições de inalação com relações de droga elevadas.
GB2416123B (en)	2007-06-06	Stable carprofen composition
GB0205347D0 (en)	2002-04-24	Biologically active complex
ITTO20010517A0 (it)	2001-05-31	Cellule progenitrici vascolari umane.
HK1081451A1 (en)	2006-05-19	Medicinal composition